{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:49:46Z","timestamp":1762422586666,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda (English Edition)"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.anpede.2021.04.006","type":"journal-article","created":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T15:42:56Z","timestamp":1645285376000},"page":"213-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs"],"prefix":"10.1016","volume":"96","author":[{"given":"Roger","family":"Esmel-Vilomara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Dolader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sabat\u00e9-Rotes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Soriano-Arandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferran","family":"Gran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferran","family":"Ros\u00e9s-Noguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpede.2021.04.006_bib0005","unstructured":"World Health Organization [Internet]. WHO Coronavirus Disease (COVID-19) Dashboard. Available from: https:\/\/who.sprinklr.com\/."},{"key":"10.1016\/j.anpede.2021.04.006_bib0010","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1096\/fj.202000919","article-title":"Rethinking the role of hydroxychloroquine in the treatment of COVID\u201019","volume":"34","author":"Meyerowitz","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.anpede.2021.04.006_bib0015","unstructured":"Ministerio de Sanidad de Espa\u00f1a [Internet]. Enfermedad por nuevo coronavirus COVID-19. Available from: https:\/\/www.mscbs.gob.es\/."},{"key":"10.1016\/j.anpede.2021.04.006_bib0020","article-title":"Screening and severity of coronavirus disease 2019 (COVID-19) in children in Madrid, Spain","author":"Tagarro","year":"2020","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.anpede.2021.04.006_bib0025","doi-asserted-by":"crossref","first-page":"422","DOI":"10.15585\/mmwr.mm6914e4","article-title":"Coronavirus Disease 2019 in Children \u2014 United States, February 12\u2013April 2, 2020","volume":"69","author":"US Department of Health & Human Services","year":"2020","journal-title":"Morb Mortal Wkly Rep (MMWR)."},{"key":"10.1016\/j.anpede.2021.04.006_bib0030","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.anpedi.2020.04.013","article-title":"Cutaneous manifestations in the current pandemic of coronavirus infection disease (COVID 2019)","volume":"92","author":"Morey-Oliv\u00e9","year":"2020","journal-title":"An Pediatr (Barc)."},{"key":"10.1016\/j.anpede.2021.04.006_bib0035","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1001\/jama.2020.8630","article-title":"Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State","volume":"323","author":"Rosenberg","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.anpede.2021.04.006_bib0040","unstructured":"US Department of Health & Human Services. Centers for Disease Control and Prevention (CDC) [internet]. Coronavirus (COVID-19). Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-nCoV\/index.html\/."},{"key":"10.1016\/j.anpede.2021.04.006_bib0045","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s40261-020-00927-1","article-title":"An updated systematic review of the therapeutic role of hydroxychloroquine in coronavirus disease-19 (COVID-19)","volume":"40","author":"Das","year":"2020","journal-title":"Clin Drug Investig."},{"key":"10.1016\/j.anpede.2021.04.006_bib0050","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.hrthm.2020.05.008","article-title":"QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: a systematic review","volume":"17","author":"Jankelson","year":"2020","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.anpede.2021.04.006_bib0055","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamacardio.2020.1834","article-title":"Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)","volume":"5","author":"Mercuro","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.anpede.2021.04.006_bib0060","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.medmal.2020.03.006","article-title":"No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection","volume":"50","author":"Molina","year":"2020","journal-title":"Med Mal Infect."},{"key":"10.1016\/j.anpede.2021.04.006_bib0065","first-page":"215","article-title":"Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol","volume":"9","author":"Naksuk","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care."},{"year":"2017","series-title":"The cardiotoxicity of antimalarials: Malaria Policy Advisory Committee Meeting","author":"World Health Organization","key":"10.1016\/j.anpede.2021.04.006_bib0070"},{"key":"10.1016\/j.anpede.2021.04.006_bib0075","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1056\/NEJMoa1003833","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1016\/j.anpede.2021.04.006_bib0080","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.hrthm.2020.06.033","article-title":"Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR positive SARS-CoV-2 infection including drug induced changes in the corrected QT interval (QTc)","volume":"17","author":"Samuel","year":"2020","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.anpede.2021.04.006_bib0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijpam.2018.12.002","article-title":"Electrocardiographic disturbances in children with systemic lupus erythematosus","volume":"5","author":"AlTwajery","year":"2018","journal-title":"Int J Pediatr Adolesc Med."},{"key":"10.1016\/j.anpede.2021.04.006_bib0090","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"10.1016\/j.anpede.2021.04.006_bib0095","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1113\/JP270526","article-title":"Predicting drug-induced QT prolongation and Torsades De Pointes","volume":"594","author":"Roden","year":"2016","journal-title":"J Physiol."},{"key":"10.1016\/j.anpede.2021.04.006_bib0100","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.celrep.2020.01.025","article-title":"Hypoxia produces pro-arrhythmic late sodium current in cardiac myocytes by SUMOylation of NaV1.5 channels","volume":"30","author":"Plant","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.anpede.2021.04.006_bib0105","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"N Engl J Med."},{"key":"10.1016\/j.anpede.2021.04.006_bib0110","doi-asserted-by":"crossref","first-page":"e906","DOI":"10.1161\/CIRCULATIONAHA.120.047521","article-title":"Considerations for drug interactions on QTc in exploratory COVID-19 treatment","volume":"141","author":"Roden","year":"2020","journal-title":"Circulation."},{"key":"10.1016\/j.anpede.2021.04.006_bib0115","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.hrthm.2015.05.027","article-title":"Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: novel electrophysiological insights and therapeutic potential","volume":"12","author":"Capel","year":"2015","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.anpede.2021.04.006_bib0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.047293","article-title":"COVID-19, arrhythmic risk and inflammation: mind the gap!","volume":"142","author":"Lazzerini","year":"2020","journal-title":"Circulation."},{"key":"10.1016\/j.anpede.2021.04.006_bib0125","article-title":"Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide\u2010spread use for COVID-19: a multinational, network cohort and self\u2010controlled case series study","author":"Lane","year":"2020","journal-title":"MedRxiv."},{"key":"10.1016\/j.anpede.2021.04.006_bib0130","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.mayocp.2020.03.024","article-title":"Urgent guidance for navigating and circumventing the QTc prolonging and torsadogenic potential of possible pharmacotherapies for COVID-19","volume":"95","author":"Giudicessi","year":"2020","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.anpede.2021.04.006_bib0135","doi-asserted-by":"crossref","first-page":"e823","DOI":"10.1161\/CIRCULATIONAHA.120.047063","volume":"141","author":"Lakkireddy","year":"2020","journal-title":"Circulation."}],"container-title":["Anales de Pediatr\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287922000254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287922000254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:44:39Z","timestamp":1762422279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2341287922000254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2341287922000254"],"URL":"https:\/\/doi.org\/10.1016\/j.anpede.2021.04.006","relation":{},"ISSN":["2341-2879"],"issn-type":[{"type":"print","value":"2341-2879"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpede.2021.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2021.04.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda.","name":"copyright","label":"Copyright"}]}}